In vitro demonstration of synergy between radionuclide and chemotherapy

Journal of Nuclear Medicine

Volumn 39, Issue 5, 1998, Pages 900-903

  Chenoufi, Norchen ^a   Raoul, Jean Luc ^a,b   Lescoat, Gérard ^a   Brissot, Pierre ^a   Bourguet, Patrick ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b CENTRE EUGÈNE MARQUIS   (France)

Author keywords

Chemoradiotherapy; Iodine 131; Radionuclide therapy

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CISPLATIN; DOXORUBICIN; FLUOROURACIL; IODINE 131; LACTATE DEHYDROGENASE;

ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG POTENTIATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DOXORUBICIN; FLUOROURACIL; HEPATOBLASTOMA; HUMANS; IODINE RADIOISOTOPES; LIVER NEOPLASMS; RADIATION TOLERANCE; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0031956321     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Wollner I, Knutsen C, Smith P, et al. Effects of hepatic arterial yttrium-90 glass microspheres in dogs. Cancer 1988;61:1336-1344.
2. Shepherd FA, Rotstein LE, Houle S, Yip TCK., Paul K., Sniderman KW. A Phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma. Cancer 1992;70:2250-2254.
3. Andrews JC, Walker SC, Acjermann RJ, Cotton LA, Ensminger WD, Shapiro B. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med 1994;35:1637-1644.
4. 131I-labelled lipiodol. I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases. Radiology 1988;168:541-545.
5. 131I-labelled lipiodol. II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases. Radiology 1988;168:547-550.
6. 131I-labeled Lipiodol. Cancer 1992;69:346-352.
7. Raoul JL, Guyader D, Bretagne JF, et al. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med 1994;35:1782-1787.
8. Raoul JL, Guyader D, Bretagne JF, et al. Prospective randomized trial of chemoembolization vs intraarterial injection of 131-labeled iodized oil in the treatment of hepatocellular carcinoma. Hepatology 1997;26:1156-1161.
9. Byfield JE, Calabro-Jones P, Klisak I, Kulhanian F. Pharmacologic requirements for obtaining sensitization of human rumor cells in vitro to combined 5-fluorouracil or ftorafur and X rays. Int J Radiat Oncol Biol Phys 1982;8:1923-1933.
10. Dimanche-Boitrel MT, Pelletier H, Genne P, et al. Confluence-dependent resistance in human colon cancer cells: role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells, Int J Cancer 1992;50:677-682.
11. Weinberg MJ, Rauth AM. 5-Fluorouracil infusions and fractionated doses of radiation: studies with a murine squamous-cell carcinoma, Int J Radiat Oncol Biol Phys 1987;13:1691-1699.
12. Vokes EE, Weichselbaum RR. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol 1990;8:911-934.
13. Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma cell lines secrete the major proteins and hepatitis B antigen. Science 1980;209:497-499.
14. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
15. Twentymann PR, Luscombe. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 1987;56:279-285.
16. Kelland LR, Steel GG, Inhibition of recovery from damage induced by ionizing radiation in mammalian cells. Radiother Oncol 1988;13:285-299.
17. Steel GG, Peckham MJ. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 1979;5:85-91.
18. Fu KK, Lam KN, Rayner PA. The influence of time sequence of cisplatin administration and continuous low dose rate irradiation (CLDRI) on their combined effects on a murine squamous cell carcinoma. Int J Radiat Oncol Biol Phys 1985;11:2119-2124.